{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:36Z","timestamp":1786649676945,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>No report is available on the treatment of primary colorectal cancer (CRC) by transarterial chemotherapy combined with lipiodol chemoembolization in tumor-feeding arteries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To determine the safety and efficacy of transarterial infusion chemotherapy (TAI) and lipiodol chemoembolization for the treatment of primary CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Thirty-seven patients with advanced CRC received TAI and lipiodol chemoembolization once a month, 1\u20133 times in all. Clinical efficacy, complications, and effectiveness were evaluated 1 month after each session.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>All 37 patients were successfully treated. The most common complications were abdominal discomfort, nausea, tenesmus, and myelosuppression. The overall disease control and objective response rates were 97.3% and 67.6%, respectively. Twenty-four patients survived and 13 died; the median survival duration was 21.1 months. Age was a significant influencing factor of overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Transarterial chemotherapy combined with lipiodol chemoembolization appears to be safe and effective for treating advanced CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2515_24","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:00:37Z","timestamp":1767189637000},"page":"1221-1226","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Transarterial infusion chemotherapy combined with iodinated oil chemoembolization for the treatment of primary colorectal cancer"],"prefix":"10.4103","volume":"21","author":[{"given":"Jiajia","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meipan","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishu","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260102","doi-asserted-by":"crossref","first-page":"113824","DOI":"10.1016\/j.addr.2021.06.001","article-title":"Advances on colorectal cancer 3D models:The needed translational technology for nanomedicine screening","volume":"175","author":"Castro","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"R2-20260102","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.soc.2017.11.010","article-title":"Surgical treatment of metastatic colorectal cancer","volume":"27","author":"Chakedis","year":"2018","journal-title":"Surg Oncol Clin N Am"},{"key":"R3-20260102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.critrevonc.2018.05.001","article-title":"Surgical treatment of pulmonary metastasis in colorectal cancer patients:Current practice and results","volume":"127","author":"Zellweger","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"R4-20260102","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11701-018-0813-6","article-title":"Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases","volume":"12","author":"Dwyer","year":"2018","journal-title":"J Robot Surg"},{"key":"R5-20260102","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"R6-20260102","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0140-6736(90)92939-F","article-title":"Targeted therapy for recurrent breast carcinoma with regional 'Lipiodol'\/epirubicin infusion","volume":"336","author":"Novell","year":"1990","journal-title":"Lancet"},{"key":"R7-20260102","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000473427","article-title":"Transcatheter arterial embolization of vesical artery in the treatment of invasive bladder cancer","volume":"15","author":"Ozono","year":"1988","journal-title":"Eur Urol"},{"key":"R8-20260102","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0959-8049(98)00153-1","article-title":"Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier","volume":"34","author":"Nagamitsu","year":"1998","journal-title":"Eur J Cancer"},{"key":"R9-20260102","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R10-20260102","first-page":"e281","article-title":"Hormone replacement therapy and colorectal cancer incidence and mortality in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"17","author":"Symer","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"R11-20260102","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jso.25920","article-title":"Optimal perfusion chemotherapy:A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer","volume":"121","author":"Woeste","year":"2020","journal-title":"J Surg Oncol"},{"key":"R12-20260102","first-page":"CD009498","article-title":"Transarterial (chemo) embolisation versus no intervention or placebo for liver metastases","volume":"3","author":"Swierz","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20260102","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bulcan.2016.10.025","article-title":"Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded)","volume":"104","author":"de Baere","year":"2017","journal-title":"Bull Cancer"},{"key":"R14-20260102","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/cancers13061371","article-title":"Review of intra-arterial therapies for colorectal cancer liver metastasis","volume":"13","author":"Kwan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R15-20260102","first-page":"CD012757","article-title":"Transarterial (chemo) embolisation versus systemic chemotherapy for colorectal cancer liver metastases","volume":"8","author":"Swierz","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20260102","doi-asserted-by":"crossref","first-page":"21985","DOI":"10.1002\/cam4.6774","article-title":"High-intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis:A propensity score-matched analysis","volume":"12","author":"Tang","year":"2023","journal-title":"Cancer Med"},{"key":"R17-20260102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1051-0443(98)70273-8","article-title":"Modification of arterial and portal hemodynamics after injection of iodized oils and different emulsions of iodized oils in the hepatic artery:An experimental study","volume":"9","author":"de Baere","year":"1998","journal-title":"J Vasc Interv Radiol"},{"key":"R18-20260102","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer:A comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"R19-20260102","first-page":"161","article-title":"Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancer","volume":"2","author":"Hobday","year":"2002","journal-title":"Clin Colorectal Cancer"},{"key":"R20-20260102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1272\/jnms.JNMS.2022_89-310","article-title":"Recent advances in the treatment of colorectal cancer:A review","volume":"89","author":"Shinji","year":"2022","journal-title":"J Nippon Med Sch"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2515_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:55Z","timestamp":1786647415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2515_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2515_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2024-12-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}